Save millions of lives by enabling early diagnosis of complex diseases.
About Scailyte
We are an innovative Swiss-based company developing artificial intelligence (AI) technology for clinical research and diagnostics. We are offering a unique solution for the discovery of novel biomarkers for ultra-sensitive and early detection of complex diseases.
Latest news
Check our latest achievements and news
Scailyte AG – an ETH Zurich Spin-off
Published on: June 6, 2018
We are proud to announce that Scailyte AG has been officially recognized as an ETH Spin-off.
2018 Class of Startups by MassChallenge Switzerland
Published on: May 31, 2018
Scailyte AG advanced to the final stage of MassChallenge Switzerland 2018 Class of Startups.
Peter Nestorov at Deep Tech & Entrepreneurship
Published on: May 7, 2018
Watch what Peter Nestorov said at Deep Tech & Entrepreneurship event in Paris, France.